Roche Holding stock last at CHF 359.40, down 1.10 percent in SIX trading
Published on 09/25/2026 at 17:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Roche Holding was last at CHF 359.40 on SWX at 4:34:56 p.m. CET on September 25, 2026, down CHF 4.00 or 1.10 percent. As finanzen.ch reported, Roche lagged a broad Swiss market advance during the morning session. The next scheduled company event is Roche's Pharmaday in London on September 28.
The session on September 25, 2026 in figures
Roche Holding AG (ISIN CH0012032048) began the SWX session at CHF 363.30 after a previous level of CHF 363.40. The shares reached a session high of CHF 364.80 and a session low of CHF 358.60. The last price stood CHF 4.00 below the previous level, a decline of 1.10 percent. SWX data recorded 169,641 shares traded at 4:34:56 p.m. CET.
The SMI stood at 13,930.40 points at 4:32:40 p.m. CET. Roche traded CHF 16.40, or 4.36 percent, below its CHF 375.80 52-week high. The stock remained CHF 107.20, or 42.51 percent, above its CHF 252.20 52-week low. The session range from CHF 358.60 to CHF 364.80 measured CHF 6.20.
Berenberg target and Swiss market drivers
Berenberg maintained its Hold rating on Roche on September 23 and set a CHF 350.00 price target. As finanzen.ch reported, analyst Luisa Hector said pharmaceutical earnings should improve through Roche's oncology position and pipeline in immunology and neurology. Hector also wrote that the share price already reflected that outlook. The report linked the rating to Roche's Pharmaday scheduled for September 28 in London.
The SMI climbed 0.82 percent to 14,019.22 points around 11:00 a.m. CET, while the SPI gained 0.83 percent to 19,869.06 points. As finanzen.ch reported, easing oil prices after a new negotiation proposal involving Iran supported sentiment. The report also cited inflation concerns, elevated energy prices, geopolitics, high bond yields and economic-growth worries.
SMI, healthcare peers and the September 25 market
The SMI's morning advance put the index above 14,000 points, while Roche traded lower in the market update. Novartis gained 0.7 percent around 11:00 a.m. CET, compared with Roche's reported 0.1 percent advance at that stage. Nestle fell 0.5 percent, while Sandoz declined 0.25 percent and Lonza lost 1.02 percent in the report's constituent table. Roche's last SWX level of CHF 359.40 at 4:34:56 p.m. CET was 3.70 percent below the morning figure of CHF 373.20 shown in the same currency, reflecting the day's later market level.
Roche Pharmaday on September 28
Roche's Pharmaday takes place in London on September 28, according to the Berenberg report. The event is relevant because Berenberg's rating note explicitly positioned its target around the meeting. Roche's next five-trading-session calendar therefore includes the company event as the principal dated item cited in the available schedule.
